Literature DB >> 10726397

[The Federal Health Survey: response, composition of participants and non-responder analysis].

W Thefeld1, H Stolzenberg, B M Bellach.   

Abstract

The first German Health Survey was carried out from October 1997 to March 1999. In the survey, 7,124 subjects of a representative sample of the residential population aged between 18 and 79 years were interviewed and medically examined. The response rate was 61.4%; 0.4% of the sample participated only partly in the study. Moreover, 16.0% of the non-respondents filled in a short questionnaire. This results in (although partly limited) information from 77.8% of the sample. The sample also comprises aliens living in Germany. More than 15% of the non-respondents could not be addressed to participate in the study because they were never reached personally. According to the statements in the short questionnaire, non-respondents and respondents differ in particular items such as e.g. education. The differences between the individual answers concerning the important question of the general health status can be classified as negligible. Weighting factors were calculated to arrive at representative information on the 18 to 79 year-old population.

Entities:  

Mesh:

Year:  1999        PMID: 10726397

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  51 in total

1.  Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey.

Authors:  Frank Jacobi; Hans-Ulrich Wittchen; Christoph Hölting; Sieghard Sommer; Roselind Lieb; Michael Höfler; Hildegard Pfister
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

2.  Nonresponse research--an underdeveloped field in epidemiology.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Widening of a social gradient in obesity risk? German national health surveys 1990 and 1998.

Authors:  Andrea Icks; Susanne Moebus; Astrid Feuersenger; Burkhard Haastert; Karl-Heinz Jöckel; Andreas Mielck; Guido Giani
Journal:  Eur J Epidemiol       Date:  2007-08-03       Impact factor: 8.082

4.  Occupations associated with a high risk of self-reported back pain: representative outcomes of a back pain prevalence study in the Federal Republic of Germany.

Authors:  Sven Schneider; Slawomira Lipinski; Marcus Schiltenwolf
Journal:  Eur Spine J       Date:  2006-01-24       Impact factor: 3.134

5.  Exposure-response relationship between endotoxin exposure and lung function impairment in cotton textile workers.

Authors:  Marcus Oldenburg; Ute Latza; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2006-10-19       Impact factor: 3.015

6.  Occupational health risks due to shipboard cockroaches.

Authors:  Marcus Oldenburg; Ute Latza; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2007-09-25       Impact factor: 3.015

7.  Trends in hospitalization and sociodemographic factors in diabetic and nondiabetic populations in Germany: national health survey, 1990-1992 and 1998.

Authors:  Andrea Icks; Burkhard Haastert; Wolfgang Rathmann; Joachim Rosenbauer; Guido Giani
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

8.  Prevalence and correlates of inflammatory arthritis in Germany: data from the First National Health Survey.

Authors:  S Schneider; G Schmitt; W Richter
Journal:  Rheumatol Int       Date:  2006-07-04       Impact factor: 2.631

9.  Hypertension in Germany.

Authors:  Hannelore Neuhauser; Claudia Diederichs; Heiner Boeing; Stephan B Felix; Claus Jünger; Roberto Lorbeer; Christine Meisinger; Annette Peters; Henry Völzke; Cornelia Weikert; Philipp Wild; Marcus Dörr
Journal:  Dtsch Arztebl Int       Date:  2016-12-02       Impact factor: 5.594

10.  Bayesian bias adjustments of the lung cancer SMR in a cohort of German carbon black production workers.

Authors:  Peter Morfeld; Robert J McCunney
Journal:  J Occup Med Toxicol       Date:  2010-08-11       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.